Published in
Wiley, British Journal of Clinical Pharmacology, 9(86), p. 1836-1848, 2020
DOI: 10.1111/bcp.14289
Links
Tools
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours
Journal article published in 2020 by
Devalingam Mahalingam,
Floris A. de Jong,
Manish R. Patel,
Jasgit C. Sachdev,
Lowell L. Hart,
Niels Halama,
Ramesh K. Ramanathan,
John Sarantopoulos,
Dirk Völkel,
Ashraf Youssef,
Floris A. Jong,
Apostolia Maria Tsimberidou 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 